Physician profile
Damian E Garcher
NPI 1427435130
$7,579.48
in general payments reported to CMS, 2019-2025
41 companies · $2,278 in 2025
The $2,278 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $535 · 2021: $1,164 · 2022: $2,216 · 2023: $1,160 · 2024: $227 · 2025: $2,278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,303 · Travel and Lodging: $1,277 · Education: $85.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,302.75 |
| Travel and Lodging | $1,277.38 |
| Education | $85.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,309.91 | 2025 | |
| Medtronic, INC. | $821.90 | 2022-2025 | Interstim |
| Astellas Pharma US INC | $695.63 | 2020-2023 | Xtandi, Myrbetriq, Veozah |
| Axonics, INC. | $589.28 | 2020-2023 | Axonics, Bulkamid |
| Myovant Sciences INC. | $541.89 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $367.19 | 2023-2025 | Orgovyx, Gemtesa |
| Abbvie INC. | $350.49 | 2020-2025 | |
| Janssen Biotech, INC. | $321.93 | 2021-2025 | Erleada |
| Teleflex LLC | $295.90 | 2021-2025 | Barrigel, Urolift |
| Boston Scientific Corporation | $240.77 | 2021-2025 | Axonics, Rezum Generator, Spaceoar Vue System - 10ml |
| Antares Pharma, INC. | $207.65 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Neotract INC. | $153.28 | 2020 | |
| Laborie Medical Technologies Corp. | $140.99 | 2022-2025 | |
| Hollister Incorporated | $138.56 | 2022-2023 | Infyna Chic |
| Dendreon Pharmaceuticals LLC | $128.96 | 2021-2025 | Provenge |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $114.86 | 2022-2025 | |
| Urovant Sciences INC | $113.34 | 2021-2022 | |
| Palette Life Sciences, INC. | $96.84 | 2022-2023 | |
| Coloplast Corp | $89.96 | 2020 | |
| Olympus America INC. | $88.98 | 2022-2025 | Itind System |
| Intuitive Surgical, INC. | $82.12 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $78.45 | 2021-2022 | |
| Srs Medical Systems, INC. | $62.63 | 2020-2025 | Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
| Pfizer INC. | $51.05 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $43.11 | 2021-2022 | |
| Biotissue Holdings INC. | $42.83 | 2021 | |
| Endo Pharmaceuticals INC. | $40.18 | 2021-2023 | Xiaflex, Aveed |
| Progenics Pharmaceuticals, INC. | $39.24 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $36.81 | 2021-2022 | |
| Verity Pharmaceuticals INC. | $34.96 | 2022-2025 | Trelstar |
| C. R. Bard, INC. & Subsidiaries | $33.70 | 2022 | |
| Medtronic USA, INC. | $31.68 | 2020 | |
| Convatec INC. | $29.19 | 2025 | |
| Genzyme Corporation | $26.83 | 2023 | |
| Dentsply Ih INC. | $24.95 | 2021 | |
| Calyxo, INC. | $24.21 | 2025 | Cvac Aspiration System |
| Travere Therapeutics, INC. | $23.02 | 2022 | |
| Tolmar, INC. | $19.73 | 2025 | Jatenzo, Eligard |
| Astrazeneca Pharmaceuticals LP | $17.67 | 2021 | |
| Angiodynamics, INC. | $14.98 | 2023 | Nanoknife |
| Ambu INC. | $13.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Damian Garcher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.